HEADER TOXIN 03-SEP-09 2RQO TITLE SOLUTION STRUCTURE OF POLYTHEONAMIDE B COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYTHEONAMIDE B; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THEONELLA SWINHOEI; SOURCE 3 ORGANISM_TAXID: 73791 KEYWDS BETA-HELIX, TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR N.HAMADA,S.MATSUNAGA,M.FUJIWARA,K.FUJJITA,H.HIROTA,R.SCHMUCKI, AUTHOR 2 P.GUNTERT,N.FUSETANI REVDAT 3 24-AUG-11 2RQO 1 MODRES REVDAT 2 27-JUL-11 2RQO 1 DBREF REVDAT 1 15-SEP-10 2RQO 0 JRNL AUTH T.HAMADA,S.MATSUNAGA,M.FUJIWARA,K.FUJITA,H.HIROTA, JRNL AUTH 2 R.SCHMUCKI,P.GUNTERT,N.FUSETANI JRNL TITL SOLUTION STRUCTURE OF POLYTHEONAMIDE B, A HIGHLY CYTOTOXIC JRNL TITL 2 NONRIBOSOMAL POLYPEPTIDE FROM MARINE SPONGE JRNL REF J.AM.CHEM.SOC. 2010 JRNL REFN ESSN 1520-5126 JRNL PMID 20795624 JRNL DOI 10.1021/JA104616Z REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 3.0, OPALP 1.4 REMARK 3 AUTHORS : P.GUNTERT ET AL. (CYANA), KORADI, R., BILLETER, REMARK 3 M., GUNTERT, P. (OPALP) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RQO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-09. REMARK 100 THE RCSB ID CODE IS RCSB150170. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2.0MM POLYTHEONAMIDE B, REMARK 210 METHANOL/CHLOROFORM REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : MOLSKOP 1.0 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, DISTANCE REMARK 210 GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 2RQO A 0 48 NOR NOR00669 NOR00669 1 49 SEQRES 1 A 49 MHE GLY I2M GLY TBG TDD TBG DAL TBG TDD ALA GLY ALA SEQRES 2 A 49 TDD ALA MND HVA GLY ALA GLY TBG MND LMQ DHV ALA GLY SEQRES 3 A 49 GLY MND ILE HTN TBG DHV GLY MND ILE MND VAL HTN ALA SEQRES 4 A 49 MND VAL DSN VAL DSG M2S DSG GLN 2TL THR HET MHE A 0 23 HET I2M A 2 22 HET TBG A 4 19 HET TDD A 5 19 HET TBG A 6 19 HET DAL A 7 10 HET TBG A 8 19 HET TDD A 9 19 HET TDD A 13 19 HET MND A 15 17 HET HVA A 16 17 HET TBG A 20 19 HET MND A 21 17 HET LMQ A 22 20 HET DHV A 23 17 HET MND A 27 17 HET HTN A 29 18 HET TBG A 30 19 HET DHV A 31 17 HET MND A 33 17 HET MND A 35 17 HET HTN A 37 18 HET MND A 39 17 HET DSN A 41 11 HET DSG A 43 14 HET M2S A 44 24 HET DSG A 45 14 HET 2TL A 47 14 HETNAM MHE 5,5-DIMETHYL-2-OXOHEXANOIC ACID HETNAM I2M 3-METHYL-L-ALLOISOLEUCINE HETNAM TBG 3-METHYL-L-VALINE HETNAM TDD (2R)-2-AMINO-3,3-DIMETHYL-BUTANOIC ACID HETNAM DAL D-ALANINE HETNAM MND N-METHYL-D-ASPARAGINE HETNAM HVA 3-HYDROXY-L-VALINE HETNAM LMQ (3S)-3-METHYL-L-GLUTAMINE HETNAM DHV 3-HYDROXY-D-VALINE HETNAM HTN (3R)-3-HYDROXY-N-METHYL-D-ASPARAGINE HETNAM DSN D-SERINE HETNAM DSG D-ASPARAGINE HETNAM M2S 3-{[(R)-METHYLSULFINYL]METHYL}-L-VALINE HETNAM 2TL D-ALLOTHREONINE HETSYN I2M BETA-METHYLISOLEUCINE HETSYN TDD D-TERT-LEUCINE HETSYN HVA L-BETA-HYDROXYVALINE HETSYN LMQ BETA-METHYLGLUTAMINE HETSYN DHV D-BETA-HYDROXYVALINE HETSYN M2S 3,3-DIMETHYL-METHIONINE SULFOXIDE FORMUL 1 MHE C8 H14 O3 FORMUL 1 I2M C7 H15 N O2 FORMUL 1 TBG 5(C6 H13 N O2) FORMUL 1 TDD 3(C6 H13 N O2) FORMUL 1 DAL C3 H7 N O2 FORMUL 1 MND 6(C5 H10 N2 O3) FORMUL 1 HVA C5 H11 N O3 FORMUL 1 LMQ C6 H12 N2 O3 FORMUL 1 DHV 2(C5 H11 N O3) FORMUL 1 HTN 2(C5 H10 N2 O4) FORMUL 1 DSN C3 H7 N O3 FORMUL 1 DSG 2(C4 H8 N2 O3) FORMUL 1 M2S C7 H15 N O3 S FORMUL 1 2TL C4 H9 N O3 LINK C1 MHE A 0 N GLY A 1 1555 1555 1.35 LINK C GLY A 1 N I2M A 2 1555 1555 1.33 LINK C I2M A 2 N GLY A 3 1555 1555 1.33 LINK C GLY A 3 N TBG A 4 1555 1555 1.33 LINK C TBG A 4 N TDD A 5 1555 1555 1.33 LINK C TDD A 5 N TBG A 6 1555 1555 1.33 LINK C TBG A 6 N DAL A 7 1555 1555 1.33 LINK C DAL A 7 N TBG A 8 1555 1555 1.33 LINK C TBG A 8 N TDD A 9 1555 1555 1.33 LINK C TDD A 9 N ALA A 10 1555 1555 1.34 LINK C ALA A 12 N TDD A 13 1555 1555 1.33 LINK C TDD A 13 N ALA A 14 1555 1555 1.33 LINK C ALA A 14 N MND A 15 1555 1555 1.33 LINK C MND A 15 N HVA A 16 1555 1555 1.34 LINK C HVA A 16 N GLY A 17 1555 1555 1.33 LINK C GLY A 19 N TBG A 20 1555 1555 1.33 LINK C TBG A 20 N MND A 21 1555 1555 1.33 LINK C MND A 21 N LMQ A 22 1555 1555 1.33 LINK C LMQ A 22 N DHV A 23 1555 1555 1.34 LINK C DHV A 23 N ALA A 24 1555 1555 1.34 LINK C GLY A 26 N MND A 27 1555 1555 1.33 LINK C MND A 27 N ILE A 28 1555 1555 1.33 LINK C ILE A 28 N HTN A 29 1555 1555 1.34 LINK C HTN A 29 N TBG A 30 1555 1555 1.33 LINK C TBG A 30 N DHV A 31 1555 1555 1.34 LINK C DHV A 31 N GLY A 32 1555 1555 1.33 LINK C GLY A 32 N MND A 33 1555 1555 1.33 LINK C MND A 33 N ILE A 34 1555 1555 1.33 LINK C ILE A 34 N MND A 35 1555 1555 1.33 LINK C MND A 35 N VAL A 36 1555 1555 1.33 LINK C VAL A 36 N HTN A 37 1555 1555 1.33 LINK C HTN A 37 N ALA A 38 1555 1555 1.33 LINK C ALA A 38 N MND A 39 1555 1555 1.33 LINK C MND A 39 N VAL A 40 1555 1555 1.33 LINK C VAL A 40 N DSN A 41 1555 1555 1.33 LINK C DSN A 41 N VAL A 42 1555 1555 1.33 LINK C VAL A 42 N DSG A 43 1555 1555 1.33 LINK C DSG A 43 N M2S A 44 1555 1555 1.33 LINK C M2S A 44 N DSG A 45 1555 1555 1.33 LINK C DSG A 45 N GLN A 46 1555 1555 1.34 LINK C GLN A 46 N 2TL A 47 1555 1555 1.33 LINK C 2TL A 47 N THR A 48 1555 1555 1.34 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 66 0 28 0 0 0 0 6 0 0 0 4 END